Your fact-checks will appear here
Independant competition authority/watchdog of the European Union concerning telecommunication within/across the EU
Randomized trials that directly tested ivermectin as post‑exposure prophylaxis (PEP) for SARS‑CoV‑2 are few, heterogeneous in design, and report mixed results — one reported a large protective effect ...
A wide range of “lipoless” branded products and lipotropic weight‑loss supplements promise fast fat loss but rest on limited evidence and uneven safety oversight — some carry known gastrointestinal si...
The World Health Organization has not endorsed ivermectin as a standard treatment for COVID‑19 and, in guidance dating to 2021 and reiterated in later summaries, recommends against use of ivermectin f...
Available public agency records and media trackers provided in the search results show no explicit mention of a product named “gelatide” in FDA approval lists, warning letters, recall databases, or re...
Clinical trials and multiple real‑world pharmacovigilance studies identify amyloid‑related imaging abnormalities (ARIA) — brain swelling (ARIA‑E) and small brain bleeds/microhemorrhages (ARIA‑H) — as ...